AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 24 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $800,000 | -75.0% | 1,000,000 | -77.8% | 0.36% | -80.2% |
| Q4 2016 | $3,206,000 | -30.5% | 4,500,000 | -35.7% | 1.81% | -37.4% |
| Q3 2016 | $4,616,000 | +8.0% | 7,000,000 | -6.7% | 2.90% | +25.9% |
| Q2 2016 | $4,275,000 | +40.2% | 7,500,000 | +25.0% | 2.30% | +158.9% |
| Q1 2016 | $3,049,000 | -60.1% | 6,000,000 | -47.8% | 0.89% | -65.8% |
| Q4 2015 | $7,633,000 | +13.5% | 11,500,000 | +27.8% | 2.59% | -10.0% |
| Q3 2015 | $6,728,000 | – | 9,000,000 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 24,200,000 | $17,243,000 | 10.27% |
| Context Capital Management, LLC | 3,910,000 | $2,830,000 | 3.10% |
| Telemetry Investments, L.L.C. | 4,500,000 | $3,206,000 | 1.81% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 65,567,000 | $47,208,000 | 0.84% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,500,000 | $21,579,000,000 | 0.42% |
| K2 PRINCIPAL FUND, L.P. | 6,000 | $4,350,000 | 0.41% |
| Tekla Capital Management LLC | 13,000,000 | $9,263,000 | 0.40% |
| Baker Brothers Advisors | 26,517,000 | $19,103,000 | 0.19% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $1,069,000 | 0.14% |
| Orbimed Advisors | 8,000,000 | $5,976,000 | 0.08% |